Common chocolate ingredient could be potent flu treatment, scientists find
The drug combination of chocolate ingredient theobromine, and the lesser-known compound arainosine, can be a potential gamechanger in treating flu, even outperforming the most widely used anti-influenza medication Tamiflu, according to the study published in the journal PNAS.
The combination therapy works by targeting a key weakness in the influenza virus, a microscopic channel the virus uses to replicate and spread.
Blocking this gate could effectively cut off the virus's ability to survive, scientists say.
Researchers found that the treatment dramatically outperformed Oseltamivir (Tamiflu) even against drug-resistant strains of the virus in both cell cultures and animal trials.
They identified this new drug combination by scanning a library of repurposed compounds originally developed for other diseases.
'We're not just offering a better flu drug, we're introducing a new way to target viruses —one that may help us prepare for future pandemics,' said study co-author Isaiah Arkin.
Influenza outbreaks challenge global public health systems every year due to unpredictable mutations undergone by the virus that counter vaccines and existing drugs.
Some strains of the virus even break out into pandemics, such as the 2009 swine flu which led to over 284,000 deaths.
Seasonal flu viruses also inflict deeper costs to poultry industries while also sparking global fears of cross-species transmission to humans.
For instance, just one recent bird flu outbreak in the US led to the loss of 40 million birds and billions in economic damage.
However, current flu treatments, like Tamiflu, are losing ground as the virus adapts.
This is because most drugs currently in use target a viral protein that mutates frequently, rendering treatments less effective over time.
Instead of this protein, the latest study targetted the flu virus' M2 ion channel, which plays a key role in its replication.
Researchers also found that the drug duo's potential for eliciting resistance from the virus is 'significantly smaller'.
'Using a combined approach, a synergistic combination of arainosine and theobromine is shown to be particularly potent against swine flu, avian flu,' scientists wrote.
'In conclusion, the outcome of this study represents a new potential treatment option for influenza alongside an approach that is sufficiently general and readily applicable to other viral targets,' they wrote.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
19 minutes ago
- The Independent
Study reveals the best type of milk to consume
A decades-long study has revealed that consuming full-fat milk increases the risk of heart disease and death, while low-fat milk is associated with lower risks. Researchers in Norway tracked health data from 73,860 individuals over 33 years, recording over 26,000 deaths, including 8,590 from cardiovascular disease. The study found that those who drank the most milk had a 22 per cent increased risk of all-cause mortality and a 12 per cent increased risk of death from cardiovascular disease. Further analysis specifically linked whole milk consumption to this increased risk, with low-fat milk associated with an 11 per cent lower mortality risk and a 7 per cent lower risk of cardiovascular disease compared to whole milk. These findings remained consistent even after excluding early deaths or participants with pre-existing conditions and align with current NHS health advice regarding saturated fat intake.
The Independent
19 minutes ago
- The Independent
Lack of this key nutrient could lead to Alzheimer's
A groundbreaking study suggests that a deficiency of naturally occurring lithium in the brain may be a key factor in the development of Alzheimer's disease. Researchers from Harvard Medical School found that lithium loss is one of the earliest changes leading to Alzheimer's, with reduced levels linked to impaired uptake and binding to amyloid plaques. The study demonstrated that a new compound, lithium orotate, can bypass amyloid plaques and successfully restore memory in mice. Unlike traditional lithium treatments, lithium orotate was effective at a significantly lower, non-toxic dose, mimicking natural brain lithium levels. These findings offer a revised understanding of Alzheimer's, suggesting new avenues for early diagnosis, prevention, and treatment, though human clinical trials are required for confirmation.
The Independent
19 minutes ago
- The Independent
New evidence of giant gas planet around ‘Earth's closest solar twin'
Astronomers have found strong evidence of a giant gas planet orbiting a star in a solar system close to our own sun. Four light-years away from Earth, the Alpha Centauri triple-star system has long been a compelling target for scientists to search for worlds outside our solar system. Now, scientists have found a lifeless planet which could be a close neighbour to Earth in astronomical terms, and could even have moons that sustain life. The potential planet, detected last year, disappeared in follow-up observations. But astronomers found new signs using NASA 's powerful James Webb Space Telescope. If confirmed, the planet would be the closest to Earth that orbits in the habitable zone of a sun-like star. "Four years is a long way but in galaxy terms, it's very close - it's in our neighbourhood," Dr Carly Howett, associate professor of space instrumentation at the University of Oxford, told the BBC. "It is around a star that is sun-like and about the same temperature and brightness. That's really important if we want to think about habitable worlds.' However, because the planet candidate is a gas giant, scientists say it would not support life as we know it. Charles Beichman, from NASA's Jet Propulsion Laboratory and the NASA Exoplanet Science Institute at Caltech's IPAC astronomy center, said: 'With this system being so close to us, any exoplanets found would offer our best opportunity to collect data on planetary systems other than our own. 'Yet, these are incredibly challenging observations to make, even with the world's most powerful space telescope, because these stars are so bright, close, and move across the sky quickly,' he added. The stars create huge amounts of bright light which can block out nearby objects, which might explain why the potential planet appeared to disappear. Mr Beichman added: 'Webb was designed and optimised to find the most distant galaxies in the universe. The operations team at the Space Telescope Science Institute had to come up with a custom observing sequence just for this target, and their extra effort paid off spectacularly.' Confirmation of the potential planet would mark a new milestone for exoplanet imaging efforts, as it would be the closest to its star to be seen so far. 'It's also the most similar in temperature and age to the giant planets in our solar system, and nearest to our home, Earth," said PhD student Aniket Sanghi of Caltech, a co-first author on the two papers covering the team's research. "Its very existence in a system of two closely separated stars would challenge our understanding of how planets form, survive, and evolve in chaotic environments." Astronomers hope to use a new telescope, NASA's Nancy Grace Roman Space Telescope, which is set to launch by May 2027, equipped with dedicated hardware to test new technologies in the search for new life.
